Literature DB >> 16906622

Orthostatic hypotension in Parkinson's disease: association with cognitive decline?

Liesl M Allcock1, Rose Anne Kenny, Urs Peter Mosimann, Sherley Tordoff, Keith A Wesnes, Anthony J Hildreth, David J Burn.   

Abstract

BACKGROUND: Orthostatic hypotension is common in Lewy body disorders and may be related to disease progression and the spread of Lewy body pathology. We therefore hypothesize that PD patients with orthostatic hypotension (OH) have a different cognitive profile compared to PD patients without OH.
METHODS: This cross-sectional study included 175 PD patients. Blood pressure (BP) was measured with a validated digital blood pressure monitor and patients with a systolic BP drop of > or =20 mmHg or a systolic pressure of <90 mm Hg after standing were considered to have OH. Cognition was assessed using MMSE extended by a selection of computerized cognitive tests focusing on reaction time, sustained attention, working memory and episodic verbal and visual memory.
RESULTS: Eighty-seven (49.7%) of the PD patients had OH. These patients were significantly more impaired in sustained attention and visual episodic memory compared to PD patients without OH.
CONCLUSION: We conclude that there are differences in the neuropsychological performance of patients with PD and OH, supporting the hypothesis that OH might be a marker for disease progression and cognitive decline in PD.

Entities:  

Mesh:

Year:  2006        PMID: 16906622     DOI: 10.1002/gps.1562

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  32 in total

Review 1.  A review of orthostatic blood pressure regulation and its association with mood and cognition.

Authors:  Lawrence C Perlmuter; Garima Sarda; Vanessa Casavant; Kimberly O'Hara; Mariah Hindes; Patrick T Knott; Aron D Mosnaim
Journal:  Clin Auton Res       Date:  2011-09-25       Impact factor: 4.435

2.  Prevalence and pattern of perceived intelligibility changes in Parkinson's disease.

Authors:  Nick Miller; Liesl Allcock; Diana Jones; Emma Noble; Anthony J Hildreth; David J Burn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-30       Impact factor: 10.154

3.  Application of the Sit-Up Test for orthostatic hypotension in individuals with stroke.

Authors:  Ada Tang; Janice J Eng; Andrei Krassioukov
Journal:  Auton Neurosci       Date:  2012-02-29       Impact factor: 3.145

Review 4.  Clinical Relevance of Orthostatic Hypotension in Neurodegenerative Disease.

Authors:  Katherine E McDonell; Cyndya A Shibao; Daniel O Claassen
Journal:  Curr Neurol Neurosci Rep       Date:  2015-12       Impact factor: 5.081

Review 5.  Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Daan C Velseboer; Rob J de Haan; Wouter Wieling; David S Goldstein; Rob M A de Bie
Journal:  Parkinsonism Relat Disord       Date:  2011-05-14       Impact factor: 4.891

Review 6.  Current pharmacological management of hypotensive syndromes in the elderly.

Authors:  Kannayiram Alagiakrishnan
Journal:  Drugs Aging       Date:  2015-05       Impact factor: 3.923

7.  Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease.

Authors:  Joong-Seok Kim; Yoon-Sang Oh; Kwang-Soo Lee; Yeong-In Kim; Dong-Won Yang; David S Goldstein
Journal:  Neurology       Date:  2012-09-12       Impact factor: 9.910

8.  Evaluation and management of the non-motor features of Parkinson's disease.

Authors:  Steven Wishart; Graeme J A Macphee
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

Review 9.  Dementia and neuroimaging.

Authors:  Federica Agosta; Francesca Caso; Massimo Filippi
Journal:  J Neurol       Date:  2012-12-15       Impact factor: 4.849

10.  Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project).

Authors:  Artur Fedorowski; Lars Stavenow; Bo Hedblad; Göran Berglund; Peter M Nilsson; Olle Melander
Journal:  Eur Heart J       Date:  2009-08-20       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.